Skip to main content
ASPIC
pt
en
Search form
Search
Toggle navigation
Home
About ASPIC
Become a member
News
Meetings
Jobs
For patients
Partners
Contacts
Home
About ASPIC
Mission
Statutes and Regulations
Committees
Reports
Make a donation
Aspic Ambassadors
Become a member
Benefits of membership
Become a member
honorary members
News
Meetings
Jobs
For patients
Partners
Contacts
Where we are
find your way to us
Associação Portuguesa de Investigação em Cancro
Send information
Exemestano
send to a friend
share this
O potencial benefício clínico do recetor de androgénio (AR) como alvo terapêutico em células de cancro de mama ER+ tratadas com Exemestano
<
Back to list
Tags:
Recetor de andrógeno
cancro da mama
Cristina Amaral
Exemestano
Georgina Correia-da-Silva
Natércia Teixeira
ASPIC
